Target intelligence / Profile preview

Metadherin pseudogene 1 (MTDHP1)

Target: MTDHP1
Molecular classification: Other (Pseudogene)

Overview

Metadherin pseudogene 1 (MTDHP1) is a genomic sequence classified as a pseudogene and is related by sequence homology to the functional Metadherin (MTDH) gene. Pseudogenes typically do not encode functional proteins and do not have known biological or therapeutic roles. MTDHP1 is distinct from the functional MTDH gene, which encodes a protein involved in cancer progression and metastasis. There is no established evidence of MTDHP1 functioning as a receptor, enzyme, or direct therapeutic target[4]. Key clarification: If you are interested in the therapeutic target with cancer relevance, you are likely seeking information about Metadherin (MTDH/AEG-1), not MTDHP1, which is simply a non-functional pseudogene unrelated to therapeutic target activities[4].

Other names: MTDHP1

Beyond the preview

Go deeper on Metadherin pseudogene 1 (MTDHP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metadherin pseudogene 1 (MTDHP1).

Explore the full profile